Literature DB >> 28465287

Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile.

Ahmed Merghani1, Viviana Maestrini1, Stefania Rosmini1, Andrew T Cox1, Harshil Dhutia1, Rachel Bastiaenan1, Sarojini David1, Tee Joo Yeo1, Rajay Narain1, Aneil Malhotra1, Michael Papadakis1, Mathew G Wilson1, Maite Tome1, Khaled AlFakih1, James C Moon1, Sanjay Sharma2.   

Abstract

BACKGROUND: Studies in middle-age and older (masters) athletes with atherosclerotic risk factors for coronary artery disease report higher coronary artery calcium (CAC) scores compared with sedentary individuals. Few studies have assessed the prevalence of coronary artery disease in masters athletes with a low atherosclerotic risk profile.
METHODS: We assessed 152 masters athletes 54.4±8.5 years of age (70% male) and 92 controls of similar age, sex, and low Framingham 10-year coronary artery disease risk scores with an echocardiogram, exercise stress test, computerized tomographic coronary angiogram, and cardiovascular magnetic resonance imaging with late gadolinium enhancement and a 24-hour Holter. Athletes had participated in endurance exercise for an average of 31±12.6 years. The majority (77%) were runners, with a median of 13 marathon runs per athlete.
RESULTS: Most athletes (60%) and controls (63%) had a normal CAC score. Male athletes had a higher prevalence of atherosclerotic plaques of any luminal irregularity (44.3% versus 22.2%; P=0.009) compared with sedentary males, and only male athletes showed a CAC ≥300 Agatston units (11.3%) and a luminal stenosis ≥50% (7.5%). Male athletes demonstrated predominantly calcific plaques (72.7%), whereas sedentary males showed predominantly mixed morphology plaques (61.5%). The number of years of training was the only independent variable associated with increased risk of CAC >70th percentile for age or luminal stenosis ≥50% in male athletes (odds ratio, 1.08; 95% confidence interval, 1.01-1.15; P=0.016); 15 (14%) male athletes but none of the controls revealed late gadolinium enhancement on cardiovascular magnetic resonance imaging. Of these athletes, 7 had a pattern consistent with previous myocardial infarction, including 3(42%) with a luminal stenosis ≥50% in the corresponding artery.
CONCLUSIONS: Most lifelong masters endurance athletes with a low atherosclerotic risk profile have normal CAC scores. Male athletes are more likely to have a CAC score >300 Agatston units or coronary plaques compared with sedentary males with a similar risk profile. The significance of these observations is uncertain, but the predominantly calcific morphology of the plaques in athletes indicates potentially different pathophysiological mechanisms for plaque formation in athletic versus sedentary men. Coronary plaques are more abundant in athletes, whereas their stable nature could mitigate the risk of plaque rupture and acute myocardial infarction.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  coronary calcification; endurance exercise; masters athletes

Mesh:

Year:  2017        PMID: 28465287     DOI: 10.1161/CIRCULATIONAHA.116.026964

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  76 in total

1.  Elite athletes as research model: vitamin D insufficiency associates with elevated central blood pressure in professional handball athletes.

Authors:  Pascal Bauer; Lutz Kraushaar; Sophie Hölscher; Shahin Tajmiri-Gondai; Oliver Dörr; Holger Nef; Christian Hamm; Astrid Most
Journal:  Eur J Appl Physiol       Date:  2019-08-19       Impact factor: 3.078

2.  The Goldilocks Zone for Exercise: Not Too Little, Not Too Much.

Authors:  James H O'Keefe; Evan L O'Keefe; Carl J Lavie
Journal:  Mo Med       Date:  2018 Mar-Apr

Review 3.  Exercise and Competitive Sport: Physiology, Adaptations, and Uncertain Long-Term Risks.

Authors:  Patrick T Gleason; Jonathan H Kim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-14

4.  Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy.

Authors:  Gherardo Finocchiaro; Harshil Dhutia; Belinda Gray; Bode Ensam; Stathis Papatheodorou; Chris Miles; Aneil Malhotra; Zeph Fanton; Paulo Bulleros; Tessa Homfray; Adam A Witney; Nicholas Bunce; Lisa J Anderson; James S Ware; Rajan Sharma; Maite Tome; Elijah R Behr; Mary N Sheppard; Michael Papadakis; Sanjay Sharma
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

5.  A comprehensive electrocardiographic analysis for young athletes.

Authors:  Hüseyin Yanık; Evren Değirmenci; Belgin Büyükakıllı
Journal:  Med Biol Eng Comput       Date:  2021-08-03       Impact factor: 2.602

Review 6.  The effects of endurance exercise on the heart: panacea or poison?

Authors:  Gemma Parry-Williams; Sanjay Sharma
Journal:  Nat Rev Cardiol       Date:  2020-03-09       Impact factor: 32.419

Review 7.  Biomarkers of Cardiac Stress and Injury in Athletes: What Do They Mean?

Authors:  Eoin Donnellan; Dermot Phelan
Journal:  Curr Heart Fail Rep       Date:  2018-04

8.  Association of All-Cause and Cardiovascular Mortality With High Levels of Physical Activity and Concurrent Coronary Artery Calcification.

Authors:  Laura F DeFina; Nina B Radford; Carolyn E Barlow; Benjamin L Willis; David Leonard; William L Haskell; Stephen W Farrell; Andjelka Pavlovic; Katelyn Abel; Jarett D Berry; Amit Khera; Benjamin D Levine
Journal:  JAMA Cardiol       Date:  2019-02-01       Impact factor: 14.676

9.  Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease.

Authors:  William E Kraus; Kenneth E Powell; William L Haskell; Kathleen F Janz; Wayne W Campbell; John M Jakicic; Richard P Troiano; Kyle Sprow; Andrea Torres; Katrina L Piercy
Journal:  Med Sci Sports Exerc       Date:  2019-06       Impact factor: 5.411

Review 10.  Cardiovascular Care of Masters Athletes.

Authors:  Timothy W Churchill; Aaron L Baggish
Journal:  J Cardiovasc Transl Res       Date:  2020-03-18       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.